RELB antibody
Quick Overview for RELB antibody (ABIN8125648)
Target
See all RELB AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- RelB Rabbit mAb
-
Specificity
- This antibody detects endogenous levels of RelB protein.
-
Purification
- The antibody was purified by protein A affinity chromatography.
-
Immunogen
- Recombinant protein (or fragment).
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB, 1:2000-1:10000 | IHC, 1:200-1:1000 | IF, 1:200-1:1000 | IP, 0. 5 μg-4 μg antibody for 200 μg-400 μg extracts of whole cells. | ELISA, Recommended starting concentration is 1 μg/mL. Please optimize the concentration based on your specific assay requirements.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- The antibody is provided in liquid form in phosphate - buffered saline with 50 % glycerol, 0.05 % BSA, and 0.05 % Proclin 300.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid freeze / thaw cycles
-
Storage
- -20 °C
-
Storage Comment
- Store at-20°C. Avoid freeze / thaw cycles.
-
-
- RELB (V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB))
-
Alternative Name
- RelB
-
Background
-
Synonyms: RELB, Transcription factor RelB, I-Rel
Background: caution:Was originally (PubMed:1577270) thought to inhibit the transcriptional activity of nuclear factor NF-kappa-B. , domain:Both N-and C-terminal domains are required for transcriptional activation. , function:NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo-or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric RelB-p50 and RelB-p52 complexes are transcriptional activators. RELB neither associates with DNA nor with RELA/p65 or REL. Stimulates promoter activity in the presence of NFKB2/p49. , induction:By mitogens. , PTM:Phosphorylation at 'Thr-103' and 'Ser-573' is followed by proteasomal degradation. , similarity:Contains 1 RHD (Rel-like) domain. , subunit:Component of the NF-kappa-B RelB-p50 complex. Component of the NF-kappa-B RelB-p52 complex. Self-associates, the interaction seems to be transient and may prevent degradation allowing for heterodimer formation with p50 or p52. Interacts with NFKB1/p50, NFKB2/p52 and NFKB2/p100. Interacts with NFKBID. ,
Gene Name: RELB
Protein Name: RelB
-
Gene ID
- 5971
-
UniProt
- Q01201
-
Pathways
- NF-kappaB Signaling, RTK Signaling
Target
-